Drugs Market Research Reports & Industry Analysis

The 2017 U.S. Drugs, health aids, beauty aids sold through Beer, wine, & liquor stores-Product & Retail Report, ... 2017 current and 2018 forecast estimates on the sales of Drugs, health aids, beauty aids sold through Beer, wine, & liquor stores nationally and for all 50 U.S. States ...

The 2017 U.S. Drugs, health aids, beauty aids sold through Gasoline stations with convenience stores-Product & Retail ... estimates on the sales of Drugs, health aids, beauty aids sold through Gasoline stations with convenience stores nationally and for all 50 U.S. States and up to 900 metro ...

The 2017 U.S. Drugs, health aids, beauty aids sold through Pharmacies & drug stores-Product & Retail Report, published annually by Barnes Reports, contains ... features 2017 current and 2018 forecast estimates on the sales of Drugs, health aids, beauty aids sold through Pharmacies & drug stores nationally and for all 50 U.S. States and ...

The 2017 U.S. Drugs, health aids, beauty aids sold through Supermarkets & other grocery (except convenience) stores-Product & ... estimates on the sales of Drugs, health aids, beauty aids sold through Supermarkets & other grocery (except convenience) stores nationally and for all 50 U.S. States and up to 900 ...

The 2017 U.S. Drugs, health aids, beauty aids, including cosmetics sold through Gift, novelty, & souvenir stores-Product & ... estimates on the sales of Drugs, health aids, beauty aids, including cosmetics sold through Gift, novelty, & souvenir stores nationally and for all 50 U.S. States and up to 900 ...

... Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing's proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project ... a 1-year online access to the data of the R&D Drug Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase. Benefits from the R&D Drug Pipeline Database ...

Anti-CD22 Immunotherapeutics in: October 2016 R&D and Business Tracker for Antibody-Drug Conjugates This pdf ... Pipeline: Anti-CD22 Immunotherapeutics CD-22Targeted Immunotherapeutics include: Naked Antibodies & Combinations Radioimmunotherapeutics Immunotoxins Antibody-Drug Conjugates Autologous CAR T-Cells Information about the anti-CD22 Immunotherapeutics pipeline ...

... : BCMA-Targeted Antibodies & T-Cellls BCMA-Targeted Antibodies & T-Cells include: Autologous & allogeneic T-Cells Bispecific tumor-targeted antibodies & T-cells Bispecific T-Cell and NK-Cell redirecting antibodies Antibody-Drug Conjugates Information about the BCMA-Targeted Antibodies & T-Cells pipeline ...

BCMA-Targeted Immunotherapeutics in: October 2016 R&D and Business Tracker for Bispecific Antibodies This pdf report contains information about Bispecific Antibodies released during the month of October 2016 ... Tracker for Bispecific Antibodies. Featured presentations of October 2016 include the pipeline of B-Cell Maturation Antigen (BCMA)-targeted immunotherapeutics, the profile of German technology company Pieris ...

... Tumor Necrosis Factor Inhibitors Approaches Used in Development of Anti-TNF TNF Inhibitors Market Overview Tumor Necrosis Factor as an Anti-Cancer Agent Global Tumor Necrosis Factor Inhibitors Pipeline by Company, Indication & Phase Global Tumor Necrosis Factor Inhibitors Pipeline: 151 Marketed Tumor Necrosis ...

... display the global Specialty Drug Distribution market. Chapter 1, to describe Specialty Drug Distribution Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Specialty Drug Distribution, with ...

The Global Parkinsons Disease Drug Industry Analysis & Forecast Market Report 2016-2021 is a professional and in-depth study on the current state of the Parkinsons Disease Drug industry. The report analysis the global market of Parkinsons Disease Drug by main manufactures and geographic regions. The report includes Parkinsons Disease Drug definitions, classifications ...

Anti-Her2 Antibody-Drug Conjugates in: September 2016 R&D and Business Tracker for Antibody-Drug Conjugates This pdf report contains information about Antibody-Drug Conjugates (ADCs) released during the month of September 2016. This ... for Antibody-Drug Conjugates. Featured presentations of September 2016 include the pipeline of Her2-targeted antibody-drug conjugates, the profile of Swiss biotech NBE Therapeutics and the profile of anti-Her2 antibody-drug conjugate MEDI4276 ...

... -2021), Global Anemia Drugs market is projected to exhibit a CAGR of over ~9.05% during 2016 - 2021. On the basis of market segment, Global Anemia Drugs Market has been segmented by Type (Iron Deficiency Anemia, Chronic Kidney ...

... contracting, and higher proof of value. Orphan drug developers need to take seriously the issues payers face and Orphan Drug Market Access: Payer Insights is a “must read” report that shows how positively working with them will have real market access benefits ...

According to Stratistics MRC, the Global Drug Discovery Technologies market is estimated at $XX million in 2015 and is expected to reach $XX million by 2022 ... and high initial cost associated with drug discovery are the factors hampering the market. Discovering drugs for diseases like Parkinson disease ...

... Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD). Intersect, is the only company that has developed drug releasing bio-absorbable implants (drug eluting sinus stents- DESS) that enable targeted and sustained release of therapeutic agents, increasing the effectiveness of the sinus ...

According to Stratistics MRC, the Global Immunotherapy Drugs market is accounted for $38.26 billion in 2015 and is expected to reach $97.47 billion by 2022 ... and R&D. Quick drug approvals is also a major factor helping the regional growth. Some of the key players of the Immunotherapy Drugs market include Aduro BioTech ...

... to increase as orphan drug price continue to rise. How can industry proactively respond to demonstrate value and support pricing? Clinical trials: As the orphan drug market ... full potential of the orphan drug market Key Topics Explored The drivers of pharma and investor interest in the potential of orphan drugs are demonstrated, as the ...

“Pancreatic Beta-cell Protection Hot Targets & Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of Pancreatic Beta-cell protection. The report covers hot targets & molecules ...

The Europe Pulmonary Drug Delivery Systems Industry Analysis & Forecast Report 2016-2021 is a professional and in-depth study on the current state of the Pulmonary Drug Delivery Systems Industry. The report ... , applications and industry chain structure. The Pulmonary Drug Delivery Systems Industry analysis is provided for the Europe markets including development trends, competitive landscape analysis ...

Renub Research report titled “Osteoporosis Companies Drugs (Merck, Sanofi, Novartis, Eli Lilly and Amgen) Sales & Forecast” provides a comprehensive analysis of the current state of the market and likely future evolution ...

... This report segments the drug discovery informatics market as follows: Drug Discovery Informatics Market: Mode Segment Analysis Outsourced Informatics In-House Informatics Drug Discovery Informatics Market: Services Segment Analysis Docking Modular Modeling Drug Discovery Informatics Market: Regional Segment ...

... Global Respiratory Drugs and Devices Market is expected to grow at a CAGR of 8% for the forecasted period of 2015-2020. Respiratory drugs market has 65% market share compared to 35% market share of respiratory devices ...

Market access for orphan drugs: Can your company break through in emerging markets? Find out which emerging markets offer the best investment prospects for orphan drug ... America Market Access Director, Leading Orphan Drug Company International Marketing Director, Europe-based orphan drug manufacturer Market Access Director, Rare Cancers-focused Biopharmaceutical Company Orphan Disease ...

... strategy and build a more compelling case for specialty drugs with FirstWord’s new report, The Cost of Specialty Drugs: Payer Perspectives. Click here to view the ... in approaches to managing specialty drug costs and the challenges faced by payers today. Read it to understand how the market is responding to rapidly rising specialty drug costs – and assess ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... , Phencyclidine (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...

This new 300-page report from VPGMarketResearch.com provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

Global drug discovery informatics market is anticipated to reach USD 6,548.1 million by 2022, according to a new ... drive the adoption of in-silicotherapeutic product discovery models thus, influencing sectorprogress over the forecast period. Drug discovery informatics industry is estimated to witness lucrative ...

... is no way the body can produce iron itself. Intravenous (IV) treatment, in a broad sense, ... the first generation drugs InFed (iron dextran) and Dexeferrum (iron dextra) and feraccru ... global iron products industry along with an extensive coverage of global, Europe and the US I.V. iron market. The global IV iron ...

... made. 1.INTRODUCTION In this report, ASKCI analyzes the financial assessment and credit risk of veterinary drug industry. It will provide you ... understanding of financial situation and credit risk on China’s veterinary drug industry; To understand position of the veterinary drug industry in China; To get more ...

... into the market for generic drugs in Japan. Key Questions Answered: What are generic drugs? How are they different from branded drugs? How has Japan’s generic drug market performed in recent years? How have generic drugs ...

... market for obesity treatments should reach more than $7.8 billion by 2021 from over $4.3 billion in 2016 increasing at a compound annual growth rate ... surgeries market should reach over $4.3 billion by 2021 from almost $3.4 billion in 2016, at a CAGR of 5.0% from 2016 to 2021. The FDA-approved drugs market ...

... from 7 viewpoints: 1. Renal Cell Carcinoma (RCC) - Disease Overview 2. Renal Cell Carcinoma (RCC) - Epidemiology 3. Global Renal Cell Carcinoma - Diagnosed Incident Cases to 2023 (8 Countries Covered) 4. Global Renal Cell Carcinoma - Five-Year Diagnosed ... (11 Brands Covered) 6. Global Renal Cell Carcinoma Drugs - Pipeline Analysis (18 Drugs Covered) 7. Global Renal Cell Carcinoma Drugs – Market Drivers and Restraints Global Renal Cell Carcinoma - Diagnosed Incident Cases ...

... “Global Injectable Drug Market: Size, Trends and Forecasts (2016-2020)” provides an in-depth analysis of the global injectable market with detailed analysis of the actual and the expected market size along ... . The competition in the global injectable drug market is stiff and dominated by the big players like Pfizer, Inc. Further, key players of the injectable drug market such as Merck ...

... a part, so which model is best and what are the considerations which underpin that choice? This report analyses current orphan drug commercial models, assesses their ... for orphan drugs commercial teams to ensure that their business model works for all stakeholders? Key components: What are the key components of current commercial models ...

... Japan Generics Drug Market Outlook 2020” Report Highlights: Introduction to Japanese Generic Drug Market Attractiveness of Japanese Generic Market Super Generics in Japan Japan Healthcare System & Generic Drugs Different Parameters for Generic & Branded Drugs Comparison of Generic Drugs in US & Japan Japan ...

2016 U.S. Drugs, health aids, beauty aids, including cosmetics sold through Other clothing stores-Product & Retail ... estimates on the sales of Drugs, health aids, beauty aids, including cosmetics sold through Other clothing stores nationally and for all 50 U.S. States and up to 900 metro ...

2016 U.S. Drugs, health aids, beauty aids, including cosmetics sold through Other home furnishings stores-Product & ... estimates on the sales of Drugs, health aids, beauty aids, including cosmetics sold through Other home furnishings stores nationally and for all 50 U.S. States and up to 900 ...

... , what can Pharma do to ensure positive payer support for its pricing proposals? Pay-for-Performance and Drug Pricing Pressure: Impact and Response from Pharma intensively examines the ... setting the pay-for-performance vs pricing status quo agenda Understand how public payers are reforming health delivery and assess the likely impact on pharma ...

... first in Belgium in 1986. Fluoxetine is a kind of selective serotonin reuptake inhibitors (SSRI) antidepressants and its medicinal form is Fluoxetine hydrochloride. Eli Lilly and ... number of Fluoxetine drugs on the market. There is a broad demand market of Fluoxetine in China. From 2010 to 2014, according to CRI’s survey on sample hospitals, CAGR of Fluoxetine is up to 9.68%. Eli ...

... more information: Market scale of Methylcobalamin in China Market Competitive pattern of Methylcobalamin in China Sales price of Methylcobalamin made by different enterprises in China Market outlook of Methylcobalamin in China The author recommends the following people to purchase this report: Production enterprises of methylcobalamin ...

... Generic Drugs Supportive Features of US Generic Drug Laws Effect of Generic Drug Import on US Economy Methods to Achieve Higher Cost Arbitrage by Generic Drugs Role of Online Pharmacies in Expansion of US Generic Drugs Market US Generic Drugs Market ...

... more drugs in various phases of clinical trials, which will help in the growth of this market. According to the report “Global Renal Cell Carcinoma Drugs Market 2020”, the renal cell carcinoma drugs market is anticipated to cross US$ 4 Billion by 2020. The report provides a detailed analysis of the market for these drugs. The ...

... friends when it comes to drug pricing. Public, health professional, political and payer hostility is growing worldwide as the prices of new drugs for chronic disease, specialty ... of justifying high drug prices to fund innovation and development need an overhaul? Risk Sharing: Are risk-sharing, value-based pricing and pricing by indication the best ...

... to Solid Tumors, attractive pricing option for orphan drug competitors and striking opportunities in developing orphan drugs. The report, “Global Orphan Drugs Market” analyzes the current prevailing condition of the ...

... ). Human insulin drugs segment is expected to account for the larger share of the global human insulin market in 2015, followed by insulin delivery devices. Significant demand growth for human insulin drugs during ... : Market Penetration: Comprehensive information on the human insulin products offered by the top 10 players in the global market. The report analyzes the human insulin market by product, drug type, drug brand ...

The global market for drug repurposing will grow from nearly ... period of 2015-2020. The U.S. dominated the drug repurposing market and should reach approximately $13.7 in 2015 and close ... billion by 2020, rising at a CAGR of 5.4%. The non-U.S. market is expected to increase from $ 10.6 billion in 2015 to nearly ...

... boost for the companies developing orphan drugs all over the world. According to the report “Global Orphan Drugs Market Outlook 2020”, the orphan drug market is anticipated to reach around US$ 180 Billion by 2020. The report provides a detailed analysis of the market for these orphan drugs. An estimation of the market ...

... research report, “Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: 65 years, 65 years; By Region; Global Dementia Market)”, global Alzheimer’s market is projected ...